SCHEMBL8601969

SCHEMBL8601969

Cc1cc(N)c(S)cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.55
TSHR P16473 4/20 0.55
MAPK1 P28482 1/20 0.55
CD44 P16070 1/20 0.42
ALDH1A1 P00352 8/20 0.39
TDP1 Q9NUW8 5/20 0.36
CASP1 P29466 1/20 0.36
TP53 P04637 2/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
ALOX15 P16050 2/20 0.33
PKM P14618 1/20 0.33
UHRF1 Q96T88 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
CYP1A2 P05177 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19370479 0.86 CYP3A4 (0.39) CYP3A4TSHRMAPK1CD44ALDH1A1
SCHEMBL11818230 0.86 CYP3A4 (0.52) CYP3A4TSHRMAPK1CD44ALDH1A1
SCHEMBL17404432 0.86 CYP3A4 (0.60) CYP3A4TSHRMAPK1CD44ALDH1A1
SCHEMBL7784067 0.80 CYP3A4 (0.60) CYP3A4TSHRMAPK1CD44ALDH1A1
SCHEMBL9737956 0.79 TSHR (0.43) CYP3A4TSHRMAPK1ALDH1A1TDP1
SCHEMBL718735 0.77 PTK2 (0.43) CYP3A4TSHRMAPK1TDP1GAA
SCHEMBL121858 0.77 CYP3A4 (0.73) CYP3A4TSHRMAPK1CD44ALDH1A1
SCHEMBL7682213 0.77 CYP3A4 (0.37) CYP3A4TSHRMAPK1ALDH1A1TDP1
SCHEMBL29388988 0.77 CYP3A4 (0.73) CYP3A4TSHRMAPK1CD44ALDH1A1
SCHEMBL716693 0.74 PTK2 (0.50) GAAPTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3470467-B1 METHINE DYES FOR COLORING PLASTICS LANXESS DEUTSCHLAND GMBH (DE) 2022-07-27 EP disclosed
CN-109666309-B Methine dyes 朗盛德国有限责任公司 2020-09-01 CN disclosed
CN-109666309-A New methine dyes 朗盛德国有限责任公司 2019-04-23 CN disclosed
US-20190112486-A1 NOVEL METHINE DYES LANXESS DEUTSCHLAND GMBH (DE) 2019-04-18 US disclosed
EP-3470467-A1 NEW METHINE DYES LANXESS Deutschland GmbH (DE) 2019-04-17 EP disclosed
EP-3470466-A1 NEW METHINE DYES LANXESS Deutschland GmbH (DE) 2019-04-17 EP disclosed
CN-101591298-A Contain 1, hydroxamic acid derivatives, the Preparation Method And The Use of 3-two assorted five-membered ring fused benzenes TIANJIN INST PHARM RESEARCH (CN) 2009-12-02 CN disclosed
EP-0614930-B1 Modified gelatin types and hydrophilic elements containing them AGFA GEVAERT NV (BE) 1998-02-04 EP disclosed
US-5439791-A Having amino, sulfinic acid or thiol end groups; enhanced reactivity with vinylsulfonyl hardeners AGFA-GEVAERT, N.V. (BE) 1995-08-08 US disclosed
US-5418231-A Pyrimido-benzothiazines PFIZER INC. (US) 1995-05-23 US disclosed
WO-1992012161-A1 NOVEL PYRIMIDO-BENZOTHIAZINES PFIZER INC. (US) 1992-07-23 WO disclosed
EP-0154838-B1 NOVEL 1,5-BENZOTHIAZEPINE DERIVATIVES, PROCESSES FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS Tanabe Seiyaku Co., Ltd. (JP) 1988-07-06 EP disclosed
US-4640916-A HYPOTENSION, ANTIISCHEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-02-03 US disclosed
EP-0186310-A1 1,4-Benzothiazine Derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1986-07-02 EP disclosed
US-4590188-A HYPOTENSIVES, VASODILATORS TANABE SEIYAKU CO., LTD. (JP) 1986-05-20 US disclosed
EP-0154838-A1 Novel 1,5-benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions Tanabe Seiyaku Co., Ltd. (JP) 1985-09-18 EP disclosed
EP-0042753-B1 NONAPEPTIDE AND DECAPEPTIDE AGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE CONTAINING HETEROCYCLIC AMINO ACID RESIDUES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOUNDS CONTAINING THEM, AND THEIR PHARMACEUTICAL USE SYNTEX (U.S.A.) INC. (US) 1984-03-21 EP disclosed
US-4318905-A Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues SYNTEX (U.S.A.) INC. (US) 1982-03-09 US disclosed
EP-0042753-A1 Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues, methods for their preparation, pharmaceutical compounds containing them, and their pharmaceutical use SYNTEX (U.S.A.) INC. (US) 1981-12-30 EP disclosed
EP-0039818-A1 Substituted 2-(3H)-benzothiazolones, processes for their preparation, their utilization in the preparation of medicines and medicines containing them Dr. Karl Thomae GmbH (DE) 1981-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190112486-A1 NOVEL METHINE DYES TET1, TET3, PRMT5 CYP3A4 907/4885TSHR 3950/4885MAPK1 2858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.